AWL5963 provides high-performance and high-reliability LDO solution as an alternative to LT1963.

In the field of portable medical devices, every milliampere-hour of battery capacity directly affects user experience and even clinical value. A domestic handheld multi-parameter vital signs monitor is designed for continuous out-of-hospital collection of electrocardiogram, blood oxygen and body temperature data, with its core analog front-end powered by an LDO regulator. The original design adopted the LT1963 to supply 3.3V power for high-precision ADCs and sensor signal chains. However, as mass production scaled up, the supply shortage of the LT1963 became increasingly severe. Meanwhile, customers reported lower-than-expected battery life of the device in low-temperature environments.

The team evaluated the AWL5963 from AnalogWin as an alternative solution, delivering remarkable results. It completely eliminates the risk of chip supply disruption and extends battery life thanks to its lower dropout voltage.

The Core of Low-Power Design: LDO Dropout Determines Battery Utilization

This device is powered by a single lithium-polymer battery with a nominal voltage of 3.7V and a typical discharge cut-off voltage of 3.2V. The LDO steadily converts battery voltage to 3.3V for analog circuits. In such applications, the LDO dropout voltage directly defines the effective usable voltage range of the battery.

According to the LT1963 datasheet, at a 1.5A load (the actual load is only 150mA with a consistent dropout trend), the typical dropout voltage is 340mV. This means when the battery voltage drops to 3.64V, the LT1963 can no longer maintain a stable 3.3V output, resulting in premature system shutdown.

By contrast, the AWL5963 features a typical dropout voltage of only 320mV under the same load conditions. This seemingly minor 20mV difference makes a notable impact on the battery discharge curve, allowing the system to operate continuously until the battery voltage drops to 3.62V before triggering under-voltage protection.

Verified Battery Life Improvement of Over 6%

A comparative test was conducted under standard conditions. Two identical prototypes equipped with the LT1963 and AWL5963 respectively ran continuously in typical operating modes at room temperature.

Test results show that the prototype with AWL5963 runs for 4 hours and 28 minutes on average, while the LT1963 version lasts 4 hours and 12 minutes, achieving approximately 6.5% longer battery life. In low-temperature testing at -10°C, exacerbated battery internal resistance and voltage drop further amplify the advantages of AWL5963, extending the runtime gap to nearly 9 minutes.

For scenarios requiring hours of continuous ECG or blood oxygen monitoring, extra operating minutes are critical for completing full data uploads.

Seamless Replacement with Zero Engineering Cost

The biggest advantage of this upgrade is hardware-free modification. Packaged in SOP8L, the AWL5963 is fully pin-to-pin compatible with the LT1963 SO-8 package. Key pins including power, ground, enable and output are identical in definition and layout. Only one 10μF low-ESR ceramic capacitor is required for peripheral circuitry, perfectly matching the original design. Engineers only need to update the BOM part number to complete the replacement, saving substantial time and costs on board revision and certification.

Uncompromised Performance and High Reliability

Beyond optimized dropout performance, the AWL5963 excels in other key specifications. Its typical output noise is only 15μV RMS, far lower than the 40μV of the LT1963, providing a cleaner power supply for high-precision bioelectrical signal acquisition. Integrated over-current, over-temperature and reverse battery protection ensure stable operation across a wide temperature range of -40°C to +125°C, fully meeting the strict safety and reliability standards of medical equipment.

Stable Supply: Relief from Supply Chain Uncertainties

Crucially, the AWL5963 is independently developed and manufactured domestically, free from international export control restrictions. Through authorized distributors such as Mandu Technology, samples are available within 3 days and mass orders are delivered in 4 weeks, putting an end to frequent production adjustments caused by the long-term LT1963 shortage.

In the fiercely competitive portable medical industry, minor improvements in user experience can create strong market competitiveness. The AWL5963 is not merely a temporary alternative for shortage mitigation, but a high-performance upgrade solution with tangible battery life gains. With a 20mV dropout optimization, it secures longer monitoring time for patients and builds a more stable supply chain for manufacturers. For designers of portable medical devices currently using the LT1963, the AWL5963 is the optimal replacement solution worthy of immediate evaluation.